Green tea-based adhesive films show promise as a novel treatment for oral mucositis
Peer-Reviewed Publication
Updates every hour. Last Updated: 29-Apr-2025 20:08 ET (30-Apr-2025 00:08 GMT/UTC)
Oral mucositis is a painful condition in which the mucous membranes inside the mouth become inflamed. To help alleviate this, researchers at the Tokyo University of Science (TUS) have developed a mucoadhesive film using xyloglucan and antioxidant-rich green tea extract containing catechins. With its strong adhesive properties, the film directly adheres to the affected area. Made from accessible ingredients, this solution could provide localized relief and improve the quality of life for patients.
With the intensifying global demand for power, cost-effective clean energy technologies are now required more than ever. Hydrovoltaic (HV) systems have recently gained significant attention for clean power generation that utilizes the interaction of water and nanostructured materials to generate electricity. Now, researchers have developed a novel dual-function HV device that also functions as a fire sensor, demonstrating, long-term viability, self-reliance, and fast response. This innovation opens new avenues for sustainable small-scale energy generation applications.
Summary
- BioChatter is an open-source Python framework for employing large language models (LLMs) in biomedical research.
- BioChatter can support the creation of dedicated LLM-driven solutions for biomedical use cases.
- AI solutions like those built using BioChatter can streamline workflows for non-computational researchers, advancing areas such as personalised medicine and drug discovery.
Researchers at CeMM and the Medical University of Vienna have developed an innovative microscopy-based approach that could predict the best approved drug to treat individual rheumatoid arthritis patients using samples of their blood. Published in the Lancet group journal EBioMedicine (DOI: 10.1016/j.ebiom.2024.105522), the study demonstrates the feasibility of precision medicine to significantly enhance treatments for rheumatoid arthritis and likely other autoimmune diseases.
A new groundbreaking pilot study carried out in France, sheds light on the numerous barriers to effective management of patients with osteoporosis. It identifies profound knowledge gaps and misinformation surrounding osteoporosis, as well as fears and uncertainties regarding its treatments.
The study was conducted by the International Osteoporosis Foundation (IOF) in partnership with the Groupe de Recherche et d’Information sur les Ostéoporoses (GRIO) and with a patient advisory group established by the Association Française de Lutte Anti-Rhumatismale (AFLAR). Its aim was to examine patient perceptions of osteoporosis, their treatment experiences, and the sources of their information.